Key findings
During this reporting period, 2,893 people across Australia participated in the TraX study and provided at least one follow-up response.
Throughout the study, monthly rates of testing for mpox remained consistent at approximately 1.0%.
Among the 2,893 participants, based on the latest survey responses provided by participants, by 21 April 2024, the proportion reporting themselves as unvaccinated against mpox has decreased by more than half to 9.2%, leaving 265 participants unvaccinated. The proportion who reported having received only one mpox vaccination also fell to 10.5% (N=305), and the proportion who had received both mpox vaccinations increased to 80.3% (N=2323).
